Thanks again for this!
The "likely" phase IIb trial details are interesting:
- 35 on placebo
- 35 on 25mg (same as phase IIa)
- 35 on unspecified dose
Would anyone happen have an idea as to whether the "unspecified dose" group is likely to be varied, or fixed?
Thanks again for this!The "likely" phase IIb trial details are...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.015(15.0%) |
Mkt cap ! $103.6M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.0¢ | $255.1K | 2.302M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1035536 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 646310 | 7 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |